
Overview
Robin is a Nurse Practitioner specializing in Oncology and Hematology. She worked for a number of years as an RN in oncology infusion centers before becoming an NP. She enjoys helping patients and guiding them through their cancer journeys.You might find Robin outside swimming in the ocean or running around the trails in SLO with her friends. She also loves to travel with her husband and kids as well as watch them compete with their swim team and out on the soccer field.
Ms. Dibiase is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Smoldering Multiple Myeloma and Myeloproliferative Neoplasms (MPN).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
715 Tank Farm Rd, Suite C, San Luis Obispo, CA 93401
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Myeloproliferative Neoplasms (MPN)Ms. Dibiase isExperienced. Learn about Myeloproliferative Neoplasms (MPN).
- Smoldering Multiple MyelomaMs. Dibiase isExperienced. Learn about Smoldering Multiple Myeloma.